{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70518-4575",
      "generic_name": "Divalproex Sodium",
      "labeler_name": "REMEDYREPACK INC.",
      "brand_name": "Divalproex Sodium",
      "active_ingredients": [
        {
          "name": "DIVALPROEX SODIUM",
          "strength": "500 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70518-4575-0",
          "description": "30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (70518-4575-0)",
          "marketing_start_date": "20260217",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, DELAYED RELEASE",
      "spl_id": "5baf1432-ca6a-a94d-e063-6394a90a3bde",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260217",
      "product_id": "70518-4575_5baf1432-ca6a-a94d-e063-6394a90a3bde",
      "application_number": "ANDA079163",
      "brand_name_base": "Divalproex Sodium",
      "pharm_class": [
        "Anti-epileptic Agent [EPC]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
        "Mood Stabilizer [EPC]"
      ]
    }
  ]
}